Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study.

Name: Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study.
Author: Lin, Haimin

Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study. — المؤلف: Lin, Haimin — OncoTargets and therapy 2019

المؤلف: Lin, Haimin
النشر: OncoTargets and therapy 2019
الوصف: 1681-1689 p.